HUM Humana Inc.

Humana and Interwell Health Announce Addition of State of Florida to Value-based Kidney Care Program

Leading health and well-being company Humana Inc. (NYSE: HUM), and kidney care management company have expanded their value-based care agreement to include Florida for eligible Humana Medicare Advantage members living with chronic kidney disease (CKD) and end-stage kidney disease (ESKD). Interwell’s value-based support services are now available in 14 states for eligible members with CKD, and in 39 states for eligible members living with ESKD.

This press release features multimedia. View the full release here:

Value-based care is a holistic, patient-centered healthcare model that focuses on a coordinated effort to help improve patient health outcomes and quality of life, and members in this program now have access throughout their healthcare journey to Interwell’s comprehensive care and specialized resources, including 2,000 network nephrologists, renal care coordinators, and in-home virtual support from dietitians, nurses, social workers, pharmacists, and care coordinators.

“Tens of millions of American adults currently live with chronic kidney disease,” said Caraline Coats, Florida Medicare President at Humana. “As the numbers continue to grow, so is the need to provide our members living with chronic and end-stage kidney disease with access to value-based, coordinated care. We are grateful to be able to bring this program to Florida.”

Humana recently documenting its success in value-based partnerships for kidney care, including a 5% reduction in unnecessary hospital admissions in 2023. That issue brief highlighted the who received a successful pre-emptive kidney transplant off the waiting list after receiving support from the Interwell care team.

"We are proud of this opportunity to serve even more Humana members with kidney disease and help them to live their best lives,” said Dr. George Hart, Chief Medical Officer of Interwell Health. “We know we can make a difference when patients receive support from a dedicated care team built to support their unique needs, while also benefiting from a highly engaged provider network committed to value-based care. Together we are improving patient outcomes.”

You can find out more information about Humana’s Kidney Care programs .

About Humana

Humana Inc. is committed to putting health first – for our teammates, our customers, and our company. Through our Humana insurance services, and our CenterWell health care services, we make it easier for the millions of people we serve to achieve their best health – delivering the care and service they need, when they need it. These efforts are leading to a better quality of life for people with Medicare, Medicaid, families, individuals, military service personnel, and communities at large. Learn more about what we offer at and at .

About Interwell Health

As a leading provider of value-based kidney care, Interwell Health is on a mission to reimagine healthcare to help patients live their best lives. Interwell is setting the standard for the industry by producing sustainable savings and driving exceptional quality results at unmatched scale. The company leverages a two-pronged approach that includes total patient care and provider enablement to serve patients with chronic kidney disease (CKD) from stage 3 to kidney failure. In partnership with more than 2,000 nephrologists, the Interwell interdisciplinary care team leverages advanced machine learning algorithms to personalize care for patients in all 50 states and Puerto Rico. To learn more, visit .

Other providers are available in the Humana network. Provider may also contract with other plan sponsors.

Y0040_GCHMG89EN_C

EN
24/09/2024

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Humana Inc.

Moody's Ratings rates Humana’s junior subordinated notes at Baa3 (hyb)

New York , March 5, 2026 - Moody's Ratings (Moody's) has assigned a Baa3 (hyb) rating to Humana Inc.'s (Humana; NYSE: HUM; senior unsecured debt rated Baa2) proposed issuance of up to $1.25 billion of junior subordinated notes. The notes will be issued under the company's existing shelf registration...

Jonathan Moreland
  • Jonathan Moreland

InsiderInsights Weekly Report: February 28, 2026

InsiderInsights Ratings of Companies with Open-Market Form 4 Purchases; Sales Filed at the SEC on the date above. We separate the real investment intelligence from the noise. Saving you time, and improving your research process

Jonathan Moreland
  • Jonathan Moreland

InsiderInsights.com Daily Ratings Report: February 25, 2026

InsiderInsights Ratings of Companies with Open-Market Form 4 Purchases; Sales Filed at the SEC on the date above. We separate the real investment intelligence from the noise. Saving you time, and improving your research process

Moody’s Ratings announces completion of a periodic review of ratings o...

New York , October 24, 2025 – Moody's Ratings (Moody's) has completed a periodic review of the ratings of Humana Inc. and other ratings that are associated with this issuer. The review was conducted through a rating committee held on 22 October 2025 in which we reassessed the appropriateness of the ...

Jonathan Moreland
  • Jonathan Moreland

Monthly Insider Special Screens: June 1, 2025

InsiderInsights Ratings of Companies with Open-Market Form 4 Purchases; Sales Filed at the SEC on the date above. We separate the real investment intelligence from the noise. Saving you time, and improving your research process

ResearchPool Subscriptions

Get the most out of your insights

Get in touch